Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fabien Despas

Showing results (51-60 of 89) with videos related to

Pageof 9
Sort By:
British Journal of Clinical Pharmacology|January 19, 2017
Identification of cellular targets involved in cardiac failure caused by PKI in oncology: an approach combining pharmacovigilance and pharmacodynamicsEmilie Patras de Campaigno, Emmanuelle Bondon-Guitton, Guy Laurent, et al.
Medicine|October 18, 2016
Drug-drug interactions with imatinib: An observational studyIsabelle Récoché, Vanessa Rousseau, Robert Bourrel, et al.
International Journal of Cardiology|February 19, 2013
Cardiorenal anemia syndrome in chronic heart failure contributes to increased sympathetic nerve activityNicolas Franchitto, Fabien Despas, Marc Labrunee, et al.
Therapie|April 25, 2019
Drug identification by the patient: Perception of patients, physicians and pharmacistsFrédéric Tranchard, Julia Gauthier, Christophe Hein, et al.
Therapie|December 30, 2020
[Adverse drug reactions profiles for abiraterone and enzalutamide: A pharmacovigilance descriptive analysis]Lucie-Marie Scailteux, Clémence Lacroix, Sandrine Bergeron, et al.
Therapie|December 13, 2017
Non-cancer drug consumption during the early trajectory of lymphoma survivorshipCatherine Rioufol, Sébastien Lamy, Cécile Conte, et al.
Fundamental & Clinical Pharmacology|June 21, 2013
Bortezomib and heart failure: case-report and review of the French Pharmacovigilance databaseBenjamin Honton, Fabien Despas, Nicolas Dumonteil, et al.
American Journal of Cardiovascular Disease|July 12, 2017
Direct evidence of sympathetic hyperactivity in patients with vasospastic anginaNicolas Boudou, Fabien Despas, Jérôme Van Rothem, et al.
Therapie|January 2, 2022
Dermatological adverse drug reactions of anticancer drugs: International data of pharmacovigilance: VigiBase®Mathilde Strumia, Marie-Loup Perrin, Emilie Patras de Compaigno, et al.
Drug Safety|July 27, 2017
Drug-Induced Dental Caries: A Disproportionality Analysis Using Data from VigiBaseEmilie Patras de Campaigno, Inès Kebir, Jean-Louis Montastruc, et al.
Pageof 9

Showing results (51-60 of 89) with videos related to

Sort By:
Pageof 9
British Journal of Clinical Pharmacology|January 19, 2017
Identification of cellular targets involved in cardiac failure caused by PKI in oncology: an approach combining pharmacovigilance and pharmacodynamicsEmilie Patras de Campaigno, Emmanuelle Bondon-Guitton, Guy Laurent, et al.
Medicine|October 18, 2016
Drug-drug interactions with imatinib: An observational studyIsabelle Récoché, Vanessa Rousseau, Robert Bourrel, et al.
International Journal of Cardiology|February 19, 2013
Cardiorenal anemia syndrome in chronic heart failure contributes to increased sympathetic nerve activityNicolas Franchitto, Fabien Despas, Marc Labrunee, et al.
Therapie|April 25, 2019
Drug identification by the patient: Perception of patients, physicians and pharmacistsFrédéric Tranchard, Julia Gauthier, Christophe Hein, et al.
Therapie|December 30, 2020
[Adverse drug reactions profiles for abiraterone and enzalutamide: A pharmacovigilance descriptive analysis]Lucie-Marie Scailteux, Clémence Lacroix, Sandrine Bergeron, et al.
Therapie|December 13, 2017
Non-cancer drug consumption during the early trajectory of lymphoma survivorshipCatherine Rioufol, Sébastien Lamy, Cécile Conte, et al.
Fundamental & Clinical Pharmacology|June 21, 2013
Bortezomib and heart failure: case-report and review of the French Pharmacovigilance databaseBenjamin Honton, Fabien Despas, Nicolas Dumonteil, et al.
American Journal of Cardiovascular Disease|July 12, 2017
Direct evidence of sympathetic hyperactivity in patients with vasospastic anginaNicolas Boudou, Fabien Despas, Jérôme Van Rothem, et al.
Therapie|January 2, 2022
Dermatological adverse drug reactions of anticancer drugs: International data of pharmacovigilance: VigiBase®Mathilde Strumia, Marie-Loup Perrin, Emilie Patras de Compaigno, et al.
Drug Safety|July 27, 2017
Drug-Induced Dental Caries: A Disproportionality Analysis Using Data from VigiBaseEmilie Patras de Campaigno, Inès Kebir, Jean-Louis Montastruc, et al.
Pageof 9